Literature DB >> 23020802

Modified and derived ethanol injection toward liposomes: development of the process.

Philippe Gentine1, Line Bourel-Bonnet, Benoît Frisch.   

Abstract

A modified and derived ethanol injection (MDEI) process was developed to produce liposomes. The aim of the present study was to more efficiently control the vesicle diameter than with the conventional ethanol injection method. A hot ethanolic solution of lipids (60°C) was injected into a hot aqueous buffer (70°C). Then, ethanol was removed by rotary evaporation under reduced pressure. The size of the liposomes could be controlled by the ratio of ethanol to hydroalcoholic solution before evaporation. The concentration of lipids, the charge of lipids, and the type of aqueous phase had little effect on the vesicle diameter when the process involved a ratio of 33% (v/v) ethanol. In addition, it was possible to obtain lipid concentrations 10- to 30-fold higher that the conventional ethanol injection method. The encapsulation of a hydrophilic compound was feasible with this MDEI process. The observation by cryogenic transmission electron microscopy revealed that these liposomes were predominantly unilamellar at a ratio as high as 33 or 50% (v/v) ethanol. Thus, the results showed that MDEI is an appropriate alternative for the manufacture of liposomes with respect to the ethanol injection process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020802     DOI: 10.3109/08982104.2012.717298

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  7 in total

1.  Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies.

Authors:  Brandon S Brown; Tariq Patanam; Keyan Mobli; Christian Celia; Peter E Zage; Andrew J Bean; Ennio Tasciotti
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

Review 2.  Nanoparticles and nanofibers for topical drug delivery.

Authors:  Ritu Goyal; Lauren K Macri; Hilton M Kaplan; Joachim Kohn
Journal:  J Control Release       Date:  2015-10-28       Impact factor: 9.776

Review 3.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

4.  Curvature sensing MARCKS-ED peptides bind to membranes in a stereo-independent manner.

Authors:  Lei Yan; Armando Jerome de Jesus; Ryo Tamura; Victoria Li; Kui Cheng; Hang Yin
Journal:  J Pept Sci       Date:  2015-04-08       Impact factor: 1.905

Review 5.  A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy.

Authors:  Min Woo Kim; Seung-Hae Kwon; Jung Hoon Choi; Aeju Lee
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

6.  Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer.

Authors:  Vijay Sagar Madamsetty; Krishnendu Pal; Shamit Kumar Dutta; Enfeng Wang; Debabrata Mukhopadhyay
Journal:  Cancers (Basel)       Date:  2020-05-08       Impact factor: 6.639

7.  Self-Assembly Behavior of Amphiphilic Janus Dendrimers in Water: A Combined Experimental and Coarse-Grained Molecular Dynamics Simulation Approach.

Authors:  Mariana E Elizondo-García; Valeria Márquez-Miranda; Ingrid Araya-Durán; Jesús A Valencia-Gallegos; Fernando D González-Nilo
Journal:  Molecules       Date:  2018-04-21       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.